ESSEX BIO-TECH released its interim results, with a profit of HKD 163 million during the period, an increase of 3.79% year-on-year
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, ESSEX BIO-TECH announced its interim results for the six months ending June 30, 2025, with a revenue of HKD 877 million, an increase of 5.79% year-on-year; the profit for the period was HKD 163 million, an increase of 3.79% year-on-year; the basic earnings per share were HKD 0.2882; and it proposed an interim dividend of HKD 0.07 per share
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments